184 results on '"Norheim G"'
Search Results
2. Avidity of IgG Antibodies Against Meningococcal Serogroup A Polysaccharide and Correlations with Bactericidal Activity in Sera From Meningitis Patients and Controls From Ethiopia
3. An Outer Membrane Vesicle Vaccine for Prevention of Serogroup A and W-135 Meningococcal Disease in the African Meningitis Belt
4. Levels of toxic and essential elements in arctic fox in Svalbard
5. Levels of environmental pollutants in flounder (Platichthys flesus L.) and cod (Gadus morhua L.) caught in the waterway of Glomma, Norway. II. Mercury and arsenic
6. Blood Selenium Levels of Norwegians Compared to Their Se Intakes
7. An OMV vaccine derived from a capsular group B meningococcus with constitutive FetA expression: preclinical evaluation of immunogenicity and toxicity
8. Levels of cadmium in liver and kidneys from Norwegian cervides
9. Detection of cod (Gadus morhua) subpopulations by chemical and statistical analysis of pollutants
10. Heavy metals in lamb liver: Contribution from atmospheric fallout
11. Levels of selenium in relation to levels of mercury in fish from Mjøsa, a freshwater lake in Southeastern Norway
12. A novel meningococcal outer membrane vesicle vaccine with constitutive expression of FetA: A phase I clinical trial
13. On the determination of molybdenum with dithiol in biological materials with high levels of copper and iron
14. New vaccine Strategies against Nesisseria meningitidis serogroup X
15. Preclinical immunogenicity and functional activity studies of an A+W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccines
16. Distribution of selenium binding proteins in liver from two species of penguins from Bouvetøya
17. The concept of ?tailor-made?, protein-based, outer membrane vesicle vaccines against meningococcal disease
18. Gas-chromatographic determination of small amounts of phenylbutazone and oxyphenbutazone in horse plasma and urine
19. Seasonal siderosis in female eider nesting in Svalbard
20. Chemical and morphological studies of liver from eider (Somateria mollissima) in Svalbard with special reference to the distribution of copper
21. The selenium-deficient rat heart with special reference to tolerance against enzymatically generated oxygen radicals.
22. A novel meningococcal outer membrane vesicle vaccine with constitutive expression of FetA: A phase I clinical trial
23. Levels of Trace Elements in Liver From Norwegian Moose, Reindeer and Red Deer in Relation To Atmospheric Deposition
24. Overvåkning av PCB, kvikksølv og kadmium i sjøvannsmiljø. Oslofjordområdet 1982-83
25. Overvåking av PCB, kvikksølv og kadmium i sjøvannsmiljø. Oslofjordområdet 1981-82
26. Grenlandsfjordene og Skienselva 1983
27. Grenlandsfjordene og Skienselva 1982
28. Decreased serum selenium in alcoholic cirrhosis
29. Grenlandsfjordene og Skienselva 1981
30. Essential trace elements in human liver in Norway: copper, zinc, molybdenum and selenium
31. [Meningococcal disease in Africa--epidemiology and prevention]
32. Persistent organochlorines and mercury in eggs of Norwegian seabirds 1983
33. Distribution and elimination of [14C]octachlorostyrene in cod(Gadus morhua), rainbow trout(Salmo gairdneri, and blue mussel(Mytilus edulis)
34. Complex formation in concentrated sulfuric acid between 1,1'-dianthrimide and germanium(IV) or tellurium(IV)
35. Levels of environmental pollutants in flounder (Platichthys flesus L.) and cod (Gadus morhua L.) caught in the waterway of Glomma, Norway. II. Mercury and arsenic
36. Distribution and elimination of ({sup}1{sup}4C)octachlorostyrene in cod (Gadus morhua), rainbow trout (Salmo gairdneri), and blue mussel (Mytilus edulis)
37. Heavy metals in lamb liver: contribution from atmospheric fallout
38. A novel SARS-CoV-2 Beta RBD DNA vaccine directly targeted to antigen-presenting cells induces strong humoral and T cell responses.
39. COVID-19 convalescent plasma from Norwegian blood donors.
40. Human B Cell Responses to Dominant and Subdominant Antigens Induced by a Meningococcal Outer Membrane Vesicle Vaccine in a Phase I Trial.
41. Mapping time use in clinical trials for vaccines against emerging infectious diseases.
42. Rift valley fever: diagnostic challenges and investment needs for vaccine development.
43. Correction to: Developing vaccines against epidemic-prone emerging infectious diseases.
44. Developing vaccines against epidemic-prone emerging infectious diseases.
45. Molecular studies of meningococcal and pneumococcal meningitis patients in Ethiopia.
46. Ample glycosylation in membrane and cell envelope proteins may explain the phenotypic diversity and virulence in the Mycobacterium tuberculosis complex.
47. Diagnostic applications for Lassa fever in limited-resource settings.
48. Genome-based transmission modelling separates imported tuberculosis from recent transmission within an immigrant population.
49. Natural immunity against capsular group X N. meningitidis following an outbreak in Togo, 2007.
50. N ε - and O-Acetylation in Mycobacterium tuberculosis Lineage 7 and Lineage 4 Strains: Proteins Involved in Bioenergetics, Virulence, and Antimicrobial Resistance Are Acetylated.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.